MedTrace Logo

Risk Factors for Postoperative Nausea and Vomiting (PONV) in Adults at the Post-Anaesthesia Care Unit of Dr. Cipto Mangunkusumo National General Hospital

NCT07688811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2026-07-14

No results posted yet for this study

Summary

The goal of this observational study is to determine the incidence of postoperative nausea and vomiting (PONV) and identify its risk factors in adult patients recovering in the post-anaesthesia care unit (PACU) after elective surgery at RSUPN Dr. Cipto Mangunkusumo, Jakarta, Indonesia. The main questions it aims to answer are:

* What is the incidence of PONV among adult patients during their PACU stay?
* Which patient-, anaesthesia-, and surgery-related factors are independently associated with the occurrence of PONV?

Participants who undergo elective surgery under any anaesthetic technique (general anaesthesia, spinal, epidural, or sedation) will be observed for nausea and vomiting from PACU admission until discharge. Researchers will also record the following variables for each participant:

* Patient factors: age, sex, smoking history, and history of motion sickness or prior PONV
* Anaesthesia factors: type of anaesthesia, intraoperative opioid use, and PONV prophylaxis use
* Surgical factors: type of surgery and surgical duration

Conditions

  • Postoperative Nausea and Vomiting
  • Anesthesia Complication
  • Postoperative Complication

Interventions

OTHER

Routine perioperative anaesthesia care

Participants undergo elective surgery with anaesthesia as part of their standard clinical care. No additional intervention is administered by the research team. The study observes participants during their routine post-anaesthesia care unit (PACU) stay and records exposure to anaesthesia-related factors (type of anaesthesia, opioid use, PONV prophylaxis) and surgical factors (surgery type, duration) as they occur in clinical practice.

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-26
Primary Completion
2026-02-26
Completion
2026-07-12

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07688811 on ClinicalTrials.gov